Catherine B Meador

10PUBLICATIONS
89CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsElectrical energy generation (incl. renewables, excl. photovoltaics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 14, 2026
Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab.

Avanish Mishra, Catherine B Meador, Kruthika Kikkeri

|Nov 26, 2025
Transcription factor-based subtype assignment in pulmonary large cell neuroendocrine carcinoma.

Yin P Hung, Komson Wannasai, Catherine B Meador

|Oct 29, 2024
Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes.

Catherine B Meador, Subba R Digumarthy, Beow Y Yeap

|Aug 23, 2024
Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer.

Takahiko Murayama, Navin R Mahadevan, Catherine B Meador

|Jun 24, 2024
Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling.

Talal El Zarif, Catherine B Meador, Xintao Qiu

|Feb 22, 2024
Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs.

Shreoshi Pal Choudhuri, Luc Girard, Jun Yi Stanley Lim

Pageof 2